Skip to main content

Biodesix Inc

BDSX
Exchange
Nasdaq
Industry
Services-Medical Laboratories
SEC CIK
0001439725

In the last 90 days, Biodesix Inc insiders filed 2 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.

Q4 2021 vs. Q3 2021

How the institutions holding Biodesix Inc changed between Q3 2021 and Q4 2021.

All holders in Q4 2021All holders in Q3 2021

13F holders of BDSX: Q3 2021 compared with Q4 2021
MeasureQ3 2021Q4 2021Change
Holders4241−1
Shares4.24M4.05M−196.7K (−4.6%)
Value$34.9M$21.4M−$13.5M (−38.7%)

New holders (6)

Institutions that held Biodesix Inc at the end of Q4 2021 but not at the end of Q3 2021.

Institutions new to BDSX in Q4 2021
InstitutionSharesValue% of portfolio
Bridgeway Capital Management, LLC105,000$555.0K0.01%
Millennium Management LLC51,895$275.0K0.00%
Chicago Capital, LLC26,965$143.0K0.01%
Nomura Holdings Inc12,361$63.0K0.00%
WoodTrust Financial Corp10,050$53.0K0.01%
Simplex Trading, LLC49$00.00%

Sold out (7)

Institutions that held Biodesix Inc at the end of Q3 2021 and filed for Q4 2021 without it.

Institutions that sold out of BDSX in Q4 2021
InstitutionShares, Q3 2021Value, Q3 2021
Oracle Investment Management Inc180,833$1.49M
Conestoga Capital Advisors, LLC115,125$946.0K
Connacht Asset Management LP90,182$741.0K
Avidian Wealth Solutions, LLC50,000$411.0K
Trexquant Investment LP18,857$155.0K
Jacobi Capital Management LLC750$6.00K
Captrust Financial Advisors109$1.00K